Study to Demonstrate Consistency of Three Lots of a Live-attenuated Chikungunya Virus Vaccine Candidate in Healthy Adults
Condition: Chikungunya Virus Infection Intervention: Biological: Biological Vaccine VLA1553 Sponsor: Valneva Austria GmbH Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials